MAPT and Alzheimer disease: The results of in vitro experiments showed that up-regulation of 24-OHC levels in an in vitro model of AD was beneficial in preventing the accumulation of over-phosphorylated Tau proteins in cells and slowing down the progression of AD (Testa et al., 2018).